Skip to Main Content

Paper Details

A randomized controlled pilot trial of anakinra for hemodialysis inflammation.
Kidney Int
7
2022
CRP, Chronic inflammation, IL-1, IL-1 receptor, IL-6, anakinra, cytopenias, hemodialysis, hemodialysis inflammation, high sensitivity C-reactive protein, hsCRP, patient, patients
Author NameAffiliation
Adriana M HungVanderbilt University Medical Center, Tennessee Valley Healthcare System
Jonathan HimmelfarbKidney Research Institute, University of Washington
Jonathan HimmelfarbKidney Research Institute, University of Washington
Talat Alp IkizlerVanderbilt University Medical Center, Tennessee Valley Healthcare System
  • 1 - 4

Datasets

Release 1.2